Analyst Consensus ?
ConsensusHold33 ratings
Bullish1236.4%
Neutral1854.5%
Bearish39.1%
FN2 Earnings Intelligence
Quest Diagnostics Incorporated analyst ratings
Quest Diagnostics Incorporated (DGX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$245.62Current
$125Low
$202.09Average
$262High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 21, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 28, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 8, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Feb 10, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 27, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Oct 21, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 23, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Dec 17, 2024 |
| B of A Securities | Buy | Buy | Maintain | Dec 13, 2024 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Feb 3, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Dec 13, 2021 |
| Argus Research | Buy | Hold | Upgrade | Oct 21, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| CFRA | Hold | Strong Buy | Downgrade | Apr 22, 2020 |
| Bank of America | Neutral | Underperform | Upgrade | Dec 19, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 24, 2019 |
| Goldman Sachs | Sell | Neutral | Downgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Jan 31, 2019 |
| William Blair | Outperform | Market Perform | Upgrade | Jun 8, 2018 |
| Raymond James | Market Perform | Outperform | Downgrade | Sep 25, 2017 |
| Jyske Bank | Sell | Sell | Maintain | Jun 24, 2016 |
| JMP Securities | Perform | Market Perform | Maintain | Mar 27, 2015 |
| ISI Group | Neutral | Neutral | Maintain | Nov 19, 2013 |
| Craig-Hallum | Buy | Buy | Maintain | Sep 19, 2013 |
| Maxim Group | Buy | Hold | Upgrade | Aug 8, 2013 |
| Oppenheimer | Underperform | Underperform | Maintain | Jan 28, 2013 |
| Macquarie | Neutral | Underperform | Upgrade | Nov 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $245.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Eric Coldwell | $262 | $243.55 | +6.7% | Oct 23, 2026 |
| UBS | Analyst unavailable | $250 | $234.03 | +1.8% | Oct 19, 2026 |
| Barclays | Luke Sergott | $260 | $228.46 | +5.9% | Oct 7, 2026 |
| Truist Financial | Analyst unavailable | $260 | $246.48 | +5.9% | Sep 21, 2026 |
| UBS | Analyst unavailable | $245 | $235.58 | -0.3% | Sep 8, 2026 |
| Argus Research | Analyst unavailable | $260 | $235.34 | +5.9% | Jul 29, 2026 |
| UBS | Kevin Caliendo | $232 | $231.3 | -5.5% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $255 | $227.9 | +3.8% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $250 | $227.9 | +1.8% | Jul 23, 2026 |
| Jefferies | Analyst unavailable | $245 | $227.9 | -0.3% | Jul 23, 2026 |
| Robert W. Baird | Analyst unavailable | $236 | $207.44 | -3.9% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $205.18 | -8.4% | Apr 21, 2026 |
| Jefferies | Analyst unavailable | $225 | $205.18 | -8.4% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $210 | $198.81 | -14.5% | Apr 8, 2026 |
| Mizuho Securities | Analyst unavailable | $235 | $209.32 | -4.3% | Feb 12, 2026 |
| UBS | Analyst unavailable | $210 | $206.72 | -14.5% | Feb 11, 2026 |
| Truist Financial | Analyst unavailable | $220 | $205.62 | -10.4% | Feb 11, 2026 |
| Evercore ISI | Elizabeth Anderson | $220 | $205.43 | -10.4% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $219 | $205.35 | -10.8% | Feb 11, 2026 |
| Jefferies | Tycho Peterson | $220 | $205.24 | -10.4% | Feb 10, 2026 |
| Barclays | Analyst unavailable | $210 | $182.35 | -14.5% | Jan 30, 2026 |
| Piper Sandler | Analyst unavailable | $200 | $182.18 | -18.6% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $205 | $184.64 | -16.5% | Oct 22, 2025 |
| Morgan Stanley | Erin Wright | $207 | $183.18 | -15.7% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $195 | $183.18 | -20.6% | Oct 22, 2025 |
| Jefferies | Analyst unavailable | $215 | $183.34 | -12.5% | Oct 21, 2025 |
| Leerink Partners | Analyst unavailable | $210 | $184.1 | -14.5% | Oct 21, 2025 |
| UBS | Kevin Caliendo | $190 | $186.82 | -22.6% | Oct 17, 2025 |
| Mizuho Securities | Analyst unavailable | $210 | $186.82 | -14.5% | Oct 17, 2025 |
| Truist Financial | Analyst unavailable | $195 | $184 | -20.6% | Oct 14, 2025 |
| Evercore ISI | Analyst unavailable | $190 | $181.89 | -22.6% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $190 | $182.07 | -22.6% | Oct 2, 2025 |
| Robert W. Baird | Analyst unavailable | $194 | $178.66 | -21.0% | Aug 25, 2025 |
| Evercore ISI | Elizabeth Anderson | $185 | $170.48 | -24.7% | Jul 23, 2025 |
| Redburn Partners | Jamie Clark | $195 | $167.96 | -20.6% | Apr 2, 2025 |
| Piper Sandler | David Westenberg | $180 | $162.47 | -26.7% | Feb 3, 2025 |
| Truist Financial | David MacDonald | $182 | $163.1 | -25.9% | Jan 31, 2025 |
| Robert W. Baird | Eric Coldwell | $189 | $163.1 | -23.1% | Jan 31, 2025 |
| Citigroup | Patrick Donnelly | $185 | $157.47 | -24.7% | Oct 23, 2024 |
| Leerink Partners | Michael Cherny | $165 | $157.47 | -32.8% | Oct 23, 2024 |
| Barclays | Stephanie Davis | $168 | $157.47 | -31.6% | Oct 23, 2024 |
| Robert W. Baird | Eric Coldwell | $182 | $157.47 | -25.9% | Oct 23, 2024 |
| CFRA | Paige Meyer | $178 | $157.46 | -27.5% | Oct 22, 2024 |
| Truist Financial | David MacDonald | $165 | $150.79 | -32.8% | Oct 7, 2024 |
| Mizuho Securities | Ann Hynes | $160 | $143.21 | -34.9% | Jul 29, 2024 |
| Robert W. Baird | Eric Coldwell | $154 | $140.96 | -37.3% | Jul 24, 2024 |
| Truist Financial | David MacDonald | $158 | $144.11 | -35.7% | Jul 15, 2024 |
| Barclays | Stephanie Davis | $144 | $137.55 | -41.4% | Apr 25, 2024 |
| Jefferies | Brian Tanquilut | $155 | $127.42 | -36.9% | Feb 7, 2024 |
| Wells Fargo | Analyst unavailable | $140 | $143.29 | -43.0% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $158 | $155.5 | -35.7% | Jan 6, 2023 |
| Citigroup | Analyst unavailable | $125 | $149.27 | -49.1% | Nov 17, 2022 |
| Morgan Stanley | Analyst unavailable | $142 | $136.13 | -42.2% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $150 | $133.75 | -38.9% | Apr 25, 2022 |
| Citigroup | Ralph Giacobbe | $175 | $140 | -28.8% | Apr 9, 2022 |
| Deutsche Bank | Pito Chickering | $190 | $142.3 | -22.6% | Jan 15, 2022 |
| KeyBanc | Donald Hooker | $170 | $161.75 | -30.8% | Dec 13, 2021 |
| Credit Suisse | A.J. Rice | $150 | $155.22 | -38.9% | Sep 9, 2021 |
Track every rating change on DGX the moment it posts. Free to start.
Start freeGet the DGX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.